2021 Medicine Grand Rounds | Mohs Micrographic Surgery and Its Utility in High-Risk Non-Melanoma Skin Cancer
City of Hope currently does not have a Mohs Micrographic Surgeon on staff at our center, with many skin cancers sent to other surgical subspecialties. Mohs Micrographic Surgery (MMS) is a surgical technique that can only be performed by a dermatologist who has done a MMS fellowship. MMS is performed on larger, high-risk cancers as well as those in cosmetically sensitive areas. MMS is the only surgical technique that examines 100% of the margin of tumor, is 99% effective (the high cure rate), and removes skin cancer with the smallest scar possible, sparing healthy tissue. Ideal practice is the referral of most high-risk, cosmetically sensitive skin cancers to a Mohs surgeon. Typically, skin cancers are referred to dermatology for biopsy for diagnosis. From there, the definitive therapy is determined by a dermatologist (radiation vs. type surgery vs. skin-directed chemotherapy). At our institution, we frequently have skin cancers referred from oncology or hematology to a surgical subspecialty. In doing this, we are not considering all therapies. In particular MMS gets overlooked, more so, because we do not have a MMS trained surgeon at our institution. Our physicians and Advance Practice Providers should be aware that this technique exists due to the high skin cancer burden among our patient population, particularly in those who have undergone transplant.
Physicians and Advanced Practice Providers.
- Identify patients in which high-risk skin cancers are a barrier to further needed immune suppressive care.
- Assess the various surgical techniques utilized to remove skin cancers and stage them appropriately.
- Examine the importance of the Mohs micrographic technique from a surgical and a pathologic perspective.
- Outline the various types of cultural diversities (gender, age, race, religion, culture, etc.) that relate to demographics, diagnosis and treatment.
Virtual Meeting- Zoom
Jenny Hu, MD, MPH Associate Professor of Clinical Dermatology; Chief, Division of Mohs and Dermatologic Surgery, Department of Dermatology; Keck School of Medicine of USC
Dr. Hu has indicated that she is a Consultant for Regeneron Pharmaceuticals.
ACCREDITATION STATEMENT: City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CREDIT DESIGNATION: City of Hope designates this live webinar for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The following credit type(s) are being offered for this course:
• AMA PRA Category 1™ 1.0
The following may apply AMA PRA Category 1 Credit™ for license renewal:
Registered Nurses: Nurses may report up to 1.0 credit hours toward the continuing education requirements for license renewal by their state Board of Registered Nurses (BRN). AMA PRA Category 1 Credit™ may be noted on the license renewal application in lieu of a BRN provider number.
Physician Assistants: The National Commission on Certification of Physicians Assistants states that AMA PRA Category 1 Credit™ accredited courses are acceptable for CME requirements for recertification.
- 1.00 AMA PRA Category 1 Credit™City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
City of Hope designates this 2021 Medicine Grand Rounds | Mohs Micrographic Surgery and Its Utility in High-Risk Non-Melanoma Skin Cancer for a maximum of 1.00 AMA PRA Category 1 Credit™ requirements. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 Attendance